找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Computer Aided Pharmaceutics and Drug Delivery; An Application Guide Vikas Anand Saharan Book 2022 Springer Nature Singapore Pte Ltd. 2022

[復(fù)制鏈接]
樓主: 和善
21#
發(fā)表于 2025-3-25 05:56:43 | 只看該作者
Ethanolamines and Secondary Products,16, the very first 3D printlet of Levetiracetam (approved by USFDA) was successfully manufactured by Aprecia Pharmaceuticals, Pennsylvania which is used to treat epilepsy. Despite the exciting recent advances in 3D printing, there are still notable scientific and regulatory obstacles. As a result, t
22#
發(fā)表于 2025-3-25 09:15:26 | 只看該作者
Ethylenediamine and Chelating Agents,d to predict the oral absorption of virtual compounds and thus offer the potential to screen the molecules under development that is having a prerequisite absorption profile. The present chapter deals with basics and recent advances along with applications and limitations of commonly used in silico
23#
發(fā)表于 2025-3-25 13:54:00 | 只看該作者
Hexamethylenetetramine (Hexamine),e primary focus is on the establishment of relationship between therapeutic drug concentration and patient response. The aim of this chapter is to discuss the role, advancement, and development of biocomputational tools used in research and development in the pharmaceutical industry, wherein the num
24#
發(fā)表于 2025-3-25 18:14:17 | 只看該作者
25#
發(fā)表于 2025-3-25 22:39:43 | 只看該作者
Ethylenediamine and Chelating Agents,s and databases which are used in clinical development of a drug product. Studies like drug interaction, dose calculations, stability studies, statistical evaluation, clinical trial study evaluation, pharmacovigilance safety extensively rely on use of softwares, databases, and computers. This chapte
26#
發(fā)表于 2025-3-26 02:03:38 | 只看該作者
Janusz Jurczak,Marek Pietraszkiewiczents, and much collaboration among companies like pharmaceuticals, medical devices, life sciences, and AI technology is observed very recently. This chapter focuses on introducing the concepts of AI, algorithms, and their applications in advancing drug discovery, formulation development, therapy, an
27#
發(fā)表于 2025-3-26 07:22:29 | 只看該作者
28#
發(fā)表于 2025-3-26 12:15:42 | 只看該作者
29#
發(fā)表于 2025-3-26 13:50:26 | 只看該作者
Thierry Lepoint,Fran?oise Lepoint-Mullielity, etc.) required in desired molecule that will influence binding affinity and helps in optimization of known ligands for designing and development of new molecules with improved activity and safety profiles. This chapter focuses on the different computational approaches such as molecular docking
30#
發(fā)表于 2025-3-26 19:04:05 | 只看該作者
K. C. Khulbe,C. Y. Feng,Takeshi Matsuura should be followed. Developed QSPR models are beneficial in predicting the biological activities of untested/new molecules, alternative of animal experiments, thus reducing animal use, refinement of synthetic targets, assumption of ADME and toxicity studies, etc. In this chapter, we focus on the va
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 10:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
西宁市| 四会市| 育儿| 贞丰县| 阳朔县| 兴国县| 普宁市| 衡南县| 延吉市| 盐山县| 乌什县| 淮滨县| 高雄市| 天峨县| 怀宁县| 得荣县| 柳河县| 中山市| 吉林省| 乌什县| 广德县| 德阳市| 迁西县| 兴宁市| 昭苏县| 舒城县| 古蔺县| 巴塘县| 都兰县| 包头市| 政和县| 叙永县| 綦江县| 简阳市| 平安县| 千阳县| 汶川县| 普格县| 织金县| 鄯善县| 富蕴县|